Market Value361,382,000
Total Holdings71
File Date2022-02-02
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
CMRX / Chimerix, Inc.
INCY / Incyte Corporation
CCXI / Churchill Capital Corp XI
AVIR / Atea Pharmaceuticals, Inc.
HRTX / Heron Therapeutics, Inc.
ZY / Zymergen Inc
DNLI / Denali Therapeutics Inc.
MRTX / Mirati Therapeutics, Inc.
HZNP / Horizon Therapeutics Plc
INSM / Insmed Incorporated
NVST / Envista Holdings Corporation
IMGN / ImmunoGen, Inc.
ARCT / Arcturus Therapeutics Holdings Inc.
AMRN / Amarin Corporation plc - Depositary Receipt (Common Stock)
ZNTL / Zentalis Pharmaceuticals, Inc.
RVNC / Revance Therapeutics, Inc.
ELV / Elevance Health, Inc.
QURE / uniQure N.V.
RLAY / Relay Therapeutics, Inc.
ZYME / Zymeworks Inc.
AVTX / Avalo Therapeutics, Inc.
FMTX / Forma Therapeutics Holdings Inc
LXRX / Lexicon Pharmaceuticals, Inc.
HOLX / Hologic, Inc.
APLS / Apellis Pharmaceuticals, Inc.
KURA / Kura Oncology, Inc.
ATRA / Atara Biotherapeutics, Inc.
AGL / agilon health, inc.
THC / Tenet Healthcare Corporation
AZN / AstraZeneca PLC - Depositary Receipt (Common Stock)
UHS / Universal Health Services, Inc.
AKRO / Akero Therapeutics, Inc.
MDT / Medtronic plc
KNSA / Kiniksa Pharmaceuticals International, plc
ONEM / 1life Healthcare Inc
SGEN / Seagen Inc
KROS / Keros Therapeutics, Inc.
BIIB / Biogen Inc.
ARNA / Arena Pharmaceuticals Inc
MGTA / Magenta Therapeutics Inc
BHVN / Biohaven Ltd.
AERI / Aerie Pharmaceuticals Inc
PTGX / Protagonist Therapeutics, Inc.
LYEL / Lyell Immunopharma, Inc.
ICPT / Intercept Pharmaceuticals Inc
DTIL / Precision BioSciences, Inc.
ABT / Abbott Laboratories
REGN / Regeneron Pharmaceuticals, Inc.
MYOV / Myovant Sciences Ltd
COR / Cencora, Inc.
AGIO / Agios Pharmaceuticals, Inc.
ACRS / Aclaris Therapeutics, Inc.
AMED / Amedisys, Inc.
LFST / LifeStance Health Group, Inc.
SIBN / SI-BONE, Inc.
MASI / Masimo Corporation
INSP / Inspire Medical Systems, Inc.
ARWR / Arrowhead Pharmaceuticals, Inc.
FATE / Fate Therapeutics, Inc.
ACHC / Acadia Healthcare Company, Inc.
MIRM / Mirum Pharmaceuticals, Inc.
NTRA / Natera, Inc.
GSK / GSK plc - Depositary Receipt (Common Stock)
ZBH / Zimmer Biomet Holdings, Inc.
BMRN / BioMarin Pharmaceutical Inc.
CNC / Centene Corporation
NTLA / Intellia Therapeutics, Inc.
RVTY / Revvity, Inc.
ITOS / iTeos Therapeutics, Inc.
IRTC / iRhythm Holdings, Inc.
REPL / Replimune Group, Inc.
RETA / Reata Pharmaceuticals Inc - Class A
NVRO / Nevro Corp.
FOLD / Amicus Therapeutics, Inc.
SAGE / Sage Therapeutics, Inc.
LH / Labcorp Holdings Inc.
ALKS / Alkermes plc
DXCM / DexCom, Inc.
PTCT / PTC Therapeutics, Inc.
BPMC / Blueprint Medicines Corporation
CVS / CVS Health Corporation
GMED / Globus Medical, Inc.
BBIO / BridgeBio Pharma, Inc. Call
PFE / Pfizer Inc.
ALNY / Alnylam Pharmaceuticals, Inc.
MCK / McKesson Corporation
MGNX / MacroGenics, Inc.
ABBV / AbbVie Inc.
LBPH / Longboard Pharmaceuticals, Inc.
EW / Edwards Lifesciences Corporation
RGNX / REGENXBIO Inc.
CYTK / Cytokinetics, Incorporated